BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= psy9688
(181 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|2VJ3|A Chain A, Human Notch-1 Egfs 11-13
Length = 135
Score = 67.8 bits (164), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 41/111 (36%), Positives = 58/111 (52%), Gaps = 12/111 (10%)
Query: 47 TDPCLGHGTCINRSDRYQCLCTPRYSGNNCEKDNGDCSSNPCLNDGVCVDEV-------- 98
+PC G CIN ++C C Y+G CE D +C SNPC ND C+D++
Sbjct: 12 ANPCEHAGKCINTLGSFECQCLQGYTGPRCEIDVNECVSNPCQNDATCLDQIGEFQCICM 71
Query: 99 --YKGRYWELPEIRDCTSNPCLNDCVCVDDGNLSFYCNCTEDFTGEYCQFE 147
Y+G + E+ +C S+PCL++ C+D N F C C FTG CQ +
Sbjct: 72 PGYEGVHCEV-NTDECASSPCLHNGRCLDKIN-EFQCECPTGFTGHLCQVD 120
Score = 38.9 bits (89), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 25/63 (39%), Positives = 38/63 (60%), Gaps = 3/63 (4%)
Query: 114 SNPCLNDCVCVDDGNLSFYCNCTEDFTGEYCQFENSAACVTLNPCQNNATCVASPGEKQI 173
+NPC + C++ SF C C + +TG C+ + + CV+ NPCQN+ATC+ GE Q
Sbjct: 12 ANPCEHAGKCINTLG-SFECQCLQGYTGPRCEIDVNE-CVS-NPCQNDATCLDQIGEFQC 68
Query: 174 TCL 176
C+
Sbjct: 69 ICM 71
Score = 33.9 bits (76), Expect = 0.050, Method: Compositional matrix adjust.
Identities = 13/38 (34%), Positives = 24/38 (63%)
Query: 42 VDHCLTDPCLGHGTCINRSDRYQCLCTPRYSGNNCEKD 79
D C + PCL +G C+++ + +QC C ++G+ C+ D
Sbjct: 83 TDECASSPCLHNGRCLDKINEFQCECPTGFTGHLCQVD 120
>pdb|1TOZ|A Chain A, Nmr Structure Of The Human Notch-1 Ligand Binding Region
Length = 116
Score = 67.4 bits (163), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 41/109 (37%), Positives = 57/109 (52%), Gaps = 12/109 (11%)
Query: 47 TDPCLGHGTCINRSDRYQCLCTPRYSGNNCEKDNGDCSSNPCLNDGVCVDEV-------- 98
+PC G CIN ++C C Y+G CE D +C SNPC ND C+D++
Sbjct: 10 ANPCEHAGKCINTLGSFECQCLQGYTGPRCEIDVNECVSNPCQNDATCLDQIGEFQCICM 69
Query: 99 --YKGRYWELPEIRDCTSNPCLNDCVCVDDGNLSFYCNCTEDFTGEYCQ 145
Y+G + E+ +C S+PCL++ C+D N F C C FTG CQ
Sbjct: 70 PGYEGVHCEV-NTDECASSPCLHNGRCLDKIN-EFQCECPTGFTGHLCQ 116
Score = 58.9 bits (141), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 31/99 (31%), Positives = 57/99 (57%), Gaps = 14/99 (14%)
Query: 14 SDINECETVKDVCNY-GICVNTNGNGNSK-------------VDHCLTDPCLGHGTCINR 59
D++EC + C + G C+NT G+ + V+ C+++PC TC+++
Sbjct: 1 QDVDECSLGANPCEHAGKCINTLGSFECQCLQGYTGPRCEIDVNECVSNPCQNDATCLDQ 60
Query: 60 SDRYQCLCTPRYSGNNCEKDNGDCSSNPCLNDGVCVDEV 98
+QC+C P Y G +CE + +C+S+PCL++G C+D++
Sbjct: 61 IGEFQCICMPGYEGVHCEVNTDECASSPCLHNGRCLDKI 99
Score = 38.1 bits (87), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 25/63 (39%), Positives = 38/63 (60%), Gaps = 3/63 (4%)
Query: 114 SNPCLNDCVCVDDGNLSFYCNCTEDFTGEYCQFENSAACVTLNPCQNNATCVASPGEKQI 173
+NPC + C++ SF C C + +TG C+ + + CV+ NPCQN+ATC+ GE Q
Sbjct: 10 ANPCEHAGKCINTLG-SFECQCLQGYTGPRCEIDVNE-CVS-NPCQNDATCLDQIGEFQC 66
Query: 174 TCL 176
C+
Sbjct: 67 ICM 69
Score = 32.7 bits (73), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 12/36 (33%), Positives = 23/36 (63%)
Query: 42 VDHCLTDPCLGHGTCINRSDRYQCLCTPRYSGNNCE 77
D C + PCL +G C+++ + +QC C ++G+ C+
Sbjct: 81 TDECASSPCLHNGRCLDKINEFQCECPTGFTGHLCQ 116
>pdb|1O5D|L Chain L, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|2B7D|L Chain L, Factor Viia Inhibitors: Chemical Optimization,
Preclinical Pharmacokinetics, Pharmacodynamics, And
Efficacy In A Baboon Thrombosis Model
pdb|2F9B|L Chain L, Discovery Of Novel Heterocyclic Factor Viia Inhibitors
pdb|2FLB|L Chain L, Discovery Of A Novel Hydroxy Pyrazole Based Factor Ixa
Inhibitor
pdb|2FLR|L Chain L, Novel 5-azaindole Factor Viia Inhibitors
pdb|3ELA|L Chain L, Crystal Structure Of Active Site Inhibited Coagulation
Factor Viia Mutant In Complex With Soluble Tissue
Factor
Length = 152
Score = 38.1 bits (87), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 21/80 (26%), Positives = 32/80 (40%)
Query: 3 FKPISLSTLCESDINECETVKDVCNYGICVNTNGNGNSKVDHCLTDPCLGHGTCINRSDR 62
+P SL C+ + E +++ S D C + PC G+C ++
Sbjct: 8 LRPGSLERECKEEQCSFEEAREIFKDAERTKLFWISYSDGDQCASSPCQNGGSCKDQLQS 67
Query: 63 YQCLCTPRYSGNNCEKDNGD 82
Y C C P + G NCE D
Sbjct: 68 YICFCLPAFEGRNCETHKDD 87
>pdb|3H5C|B Chain B, X-Ray Structure Of Protein Z-Protein Z Inhibitor Complex
Length = 317
Score = 37.4 bits (85), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 19/48 (39%), Positives = 28/48 (58%), Gaps = 2/48 (4%)
Query: 45 CLTDPCLGHGTCINRSDRYQCLCTPRYSGNNCEKDNGDCSSNPCLNDG 92
C++ PCL +G+C + Y C C+P Y G+NCE +C +P DG
Sbjct: 8 CISQPCLHNGSCQDSIWGYTCTCSPGYEGSNCELAKNEC--HPERTDG 53
>pdb|2RQZ|A Chain A, Structure Of Sugar Modified Epidermal Growth Factor-Like
Repeat 12 Of Mouse Notch-1 Receptor
pdb|2RR0|A Chain A, Structure Of Epidermal Growth Factor-Like Repeat 12 Of
Mouse Notch-1 Receptor
pdb|2RR2|A Chain A, Structure Of O-Fucosylated Epidermal Growth Factor-Like
Repeat 12 Of Mouse Notch-1 Receptor
Length = 38
Score = 37.4 bits (85), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 14/36 (38%), Positives = 23/36 (63%)
Query: 42 VDHCLTDPCLGHGTCINRSDRYQCLCTPRYSGNNCE 77
V+ C+++PC TC+++ +QC+C P Y G CE
Sbjct: 2 VNECISNPCQNDATCLDQIGEFQCICMPGYEGVYCE 37
Score = 31.2 bits (69), Expect = 0.36, Method: Compositional matrix adjust.
Identities = 15/39 (38%), Positives = 21/39 (53%), Gaps = 1/39 (2%)
Query: 108 EIRDCTSNPCLNDCVCVDDGNLSFYCNCTEDFTGEYCQF 146
++ +C SNPC ND C+D F C C + G YC+
Sbjct: 1 DVNECISNPCQNDATCLDQIG-EFQCICMPGYEGVYCEI 38
Score = 27.7 bits (60), Expect = 3.6, Method: Compositional matrix adjust.
Identities = 12/21 (57%), Positives = 15/21 (71%)
Query: 156 NPCQNNATCVASPGEKQITCL 176
NPCQN+ATC+ GE Q C+
Sbjct: 8 NPCQNDATCLDQIGEFQCICM 28
Score = 26.2 bits (56), Expect = 9.4, Method: Compositional matrix adjust.
Identities = 14/38 (36%), Positives = 20/38 (52%), Gaps = 10/38 (26%)
Query: 79 DNGDCSSNPCLNDGVCVDEV----------YKGRYWEL 106
D +C SNPC ND C+D++ Y+G Y E+
Sbjct: 1 DVNECISNPCQNDATCLDQIGEFQCICMPGYEGVYCEI 38
>pdb|1F7E|A Chain A, The First Egf-Like Domain From Human Blood Coagulation
Fvii, Nmr, 20 Structures
pdb|1F7M|A Chain A, The First Egf-Like Domain From Human Blood Coagulation
Fvii, Nmr, Minimized Average Structure
pdb|1FF7|A Chain A, The First Egf-Like Domain From Human Blood Coagulation
Fvii (Fucosylated At Ser-60), Nmr, 20 Structures
pdb|1FFM|A Chain A, The First Egf-Like Domain From Human Blood Coagulation
Fvii (Fucosylated At Ser-60), Nmr, Minimized Average
Structure
Length = 46
Score = 36.6 bits (83), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 18/44 (40%), Positives = 24/44 (54%), Gaps = 2/44 (4%)
Query: 40 SKVDHCLTDPCLGHGTCINRSDRYQCLCTPRYSGNNCE--KDNG 81
S D C + PC G+C ++ Y C C P + G NCE KD+G
Sbjct: 1 SDGDQCASSPCQNGGSCKDQLQSYICFCLPAFEGRNCETHKDDG 44
>pdb|1U67|A Chain A, Crystal Structure Of Arachidonic Acid Bound To A Mutant
Of Prostagladin H Synthase-1 That Forms Predominantly
11-hpete
Length = 600
Score = 35.8 bits (81), Expect = 0.012, Method: Composition-based stats.
Identities = 18/39 (46%), Positives = 21/39 (53%), Gaps = 2/39 (5%)
Query: 40 SKVDHCLTDPCLGHGTCINRS-DRYQCLCTPR-YSGNNC 76
+ V+ C PC G C+ DRYQC CT YSG NC
Sbjct: 31 APVNPCCYYPCQHQGICVRFGLDRYQCDCTRTGYSGPNC 69
>pdb|1PTH|A Chain A, The Structural Basis Of Aspirin Activity Inferred From
The Crystal Structure Of Inactivated Prostaglandin H2
Synthase
pdb|1PTH|B Chain B, The Structural Basis Of Aspirin Activity Inferred From
The Crystal Structure Of Inactivated Prostaglandin H2
Synthase
Length = 576
Score = 35.8 bits (81), Expect = 0.012, Method: Composition-based stats.
Identities = 18/39 (46%), Positives = 21/39 (53%), Gaps = 2/39 (5%)
Query: 40 SKVDHCLTDPCLGHGTCINRS-DRYQCLCTPR-YSGNNC 76
+ V+ C PC G C+ DRYQC CT YSG NC
Sbjct: 7 APVNPCCYYPCQHQGICVRFGLDRYQCDCTRTGYSGPNC 45
>pdb|2OYE|P Chain P, Indomethacin-(r)-alpha-ethyl-ethanolamide Bound To
Cyclooxygenase-1
pdb|2OYU|P Chain P, Indomethacin-(S)-Alpha-Ethyl-Ethanolamide Bound To
Cyclooxygenase-1
Length = 600
Score = 35.8 bits (81), Expect = 0.012, Method: Composition-based stats.
Identities = 18/39 (46%), Positives = 21/39 (53%), Gaps = 2/39 (5%)
Query: 40 SKVDHCLTDPCLGHGTCINRS-DRYQCLCTPR-YSGNNC 76
+ V+ C PC G C+ DRYQC CT YSG NC
Sbjct: 31 APVNPCCYYPCQHQGICVRFGLDRYQCDCTRTGYSGPNC 69
>pdb|1PGE|A Chain A, Prostaglandin H2 Synthase-1 Complexed With
P-(2'-Iodo-5'-Thenoyl) Hydrotropic Acid (Iodosuprofen)
pdb|1PGE|B Chain B, Prostaglandin H2 Synthase-1 Complexed With
P-(2'-Iodo-5'-Thenoyl) Hydrotropic Acid (Iodosuprofen)
pdb|1PGF|A Chain A, Prostaglandin H2 Synthase-1 Complexed With
1-(4-Iodobenzoyl)-5- Methoxy-2-Methylindole-3-Acetic
Acid (Iodoindomethacin), Cis Model
pdb|1PGF|B Chain B, Prostaglandin H2 Synthase-1 Complexed With
1-(4-Iodobenzoyl)-5- Methoxy-2-Methylindole-3-Acetic
Acid (Iodoindomethacin), Cis Model
pdb|1PGG|A Chain A, Prostaglandin H2 Synthase-1 Complexed With
1-(4-Iodobenzoyl)-5- Methoxy-2-Methylindole-3-Acetic
Acid (Iodoindomethacin), Trans Model
pdb|1PGG|B Chain B, Prostaglandin H2 Synthase-1 Complexed With
1-(4-Iodobenzoyl)-5- Methoxy-2-Methylindole-3-Acetic
Acid (Iodoindomethacin), Trans Model
pdb|1FE2|A Chain A, Crystal Structure Of Dihomo-Gamma-Linoleic Acid Bound In
The Cyclooxygenase Channel Of Prostaglandin
Endoperoxide H Synthase-1.
pdb|1IGZ|A Chain A, Crystal Structure Of Linoleic Acid Bound In The
Cyclooxygenase Channel Of Prostaglandin Endoperoxide H
Synthase-1.
pdb|1IGX|A Chain A, Crystal Structure Of Eicosapentanoic Acid Bound In The
Cyclooxygenase Channel Of Prostaglandin Endoperoxide H
Synthase-1
Length = 576
Score = 35.8 bits (81), Expect = 0.012, Method: Composition-based stats.
Identities = 18/39 (46%), Positives = 21/39 (53%), Gaps = 2/39 (5%)
Query: 40 SKVDHCLTDPCLGHGTCINRS-DRYQCLCTPR-YSGNNC 76
+ V+ C PC G C+ DRYQC CT YSG NC
Sbjct: 7 APVNPCCYYPCQHQGICVRFGLDRYQCDCTRTGYSGPNC 45
>pdb|1CQE|A Chain A, Prostaglandin H2 Synthase-1 Complex With Flurbiprofen
pdb|1CQE|B Chain B, Prostaglandin H2 Synthase-1 Complex With Flurbiprofen
pdb|1EQG|A Chain A, The 2.6 Angstrom Model Of Ovine Cox-1 Complexed With
Ibuprofen
pdb|1EQG|B Chain B, The 2.6 Angstrom Model Of Ovine Cox-1 Complexed With
Ibuprofen
pdb|1EQH|A Chain A, The 2.7 Angstrom Model Of Ovine Cox-1 Complexed With
Flurbiprofen
pdb|1EQH|B Chain B, The 2.7 Angstrom Model Of Ovine Cox-1 Complexed With
Flurbiprofen
Length = 580
Score = 35.8 bits (81), Expect = 0.012, Method: Composition-based stats.
Identities = 18/39 (46%), Positives = 21/39 (53%), Gaps = 2/39 (5%)
Query: 40 SKVDHCLTDPCLGHGTCINRS-DRYQCLCTPR-YSGNNC 76
+ V+ C PC G C+ DRYQC CT YSG NC
Sbjct: 11 APVNPCCYYPCQHQGICVRFGLDRYQCDCTRTGYSGPNC 49
>pdb|3N8Y|B Chain B, Structure Of Aspirin Acetylated Cyclooxygenase-1 In
Complex With Diclofenac
Length = 553
Score = 35.8 bits (81), Expect = 0.012, Method: Composition-based stats.
Identities = 18/37 (48%), Positives = 20/37 (54%), Gaps = 2/37 (5%)
Query: 42 VDHCLTDPCLGHGTCINRS-DRYQCLCTPR-YSGNNC 76
V+ C PC G C+ DRYQC CT YSG NC
Sbjct: 2 VNPCCYYPCQHQGICVRFGLDRYQCDCTRTGYSGPNC 38
>pdb|3N8W|B Chain B, Crystal Structure Of R120qNATIVE CYCLOOXYGENASE-1
Heterodimer Mutant In Complex With Flurbiprofen
Length = 553
Score = 35.8 bits (81), Expect = 0.012, Method: Composition-based stats.
Identities = 18/37 (48%), Positives = 20/37 (54%), Gaps = 2/37 (5%)
Query: 42 VDHCLTDPCLGHGTCINRS-DRYQCLCTPR-YSGNNC 76
V+ C PC G C+ DRYQC CT YSG NC
Sbjct: 2 VNPCCYYPCQHQGICVRFGLDRYQCDCTRTGYSGPNC 38
>pdb|1DIY|A Chain A, Crystal Structure Of Arachidonic Acid Bound In The
Cyclooxygenase Active Site Of Pghs-1
pdb|1Q4G|A Chain A, 2.0 Angstrom Crystal Structure Of Ovine Prostaglandin H2
Synthase-1, In Complex With
Alpha-Methyl-4-Biphenylacetic Acid
pdb|1Q4G|B Chain B, 2.0 Angstrom Crystal Structure Of Ovine Prostaglandin H2
Synthase-1, In Complex With
Alpha-Methyl-4-Biphenylacetic Acid
pdb|2AYL|A Chain A, 2.0 Angstrom Crystal Structure Of Manganese
Protoporphyrin Ix- Reconstituted Ovine Prostaglandin H2
Synthase-1 Complexed With Flurbiprofen
pdb|2AYL|B Chain B, 2.0 Angstrom Crystal Structure Of Manganese
Protoporphyrin Ix- Reconstituted Ovine Prostaglandin H2
Synthase-1 Complexed With Flurbiprofen
pdb|3KK6|A Chain A, Crystal Structure Of Cyclooxygenase-1 In Complex With
Celecoxib
pdb|3KK6|B Chain B, Crystal Structure Of Cyclooxygenase-1 In Complex With
Celecoxib
pdb|3N8V|A Chain A, Crystal Structure Of Unoccupied Cyclooxygenase-1
pdb|3N8V|B Chain B, Crystal Structure Of Unoccupied Cyclooxygenase-1
pdb|3N8W|A Chain A, Crystal Structure Of R120qNATIVE CYCLOOXYGENASE-1
Heterodimer Mutant In Complex With Flurbiprofen
pdb|3N8X|A Chain A, Crystal Structure Of Cyclooxygenase-1 In Complex With
Nimesulide
pdb|3N8X|B Chain B, Crystal Structure Of Cyclooxygenase-1 In Complex With
Nimesulide
pdb|3N8Y|A Chain A, Structure Of Aspirin Acetylated Cyclooxygenase-1 In
Complex With Diclofenac
pdb|3N8Z|A Chain A, Crystal Structure Of Cyclooxygenase-1 In Complex With
Flurbiprofen
pdb|3N8Z|B Chain B, Crystal Structure Of Cyclooxygenase-1 In Complex With
Flurbiprofen
Length = 553
Score = 35.8 bits (81), Expect = 0.012, Method: Composition-based stats.
Identities = 18/37 (48%), Positives = 20/37 (54%), Gaps = 2/37 (5%)
Query: 42 VDHCLTDPCLGHGTCINRS-DRYQCLCTPR-YSGNNC 76
V+ C PC G C+ DRYQC CT YSG NC
Sbjct: 2 VNPCCYYPCQHQGICVRFGLDRYQCDCTRTGYSGPNC 38
>pdb|1HT5|A Chain A, The 2.75 Angstrom Resolution Model Of Ovine Cox-1
Complexed With Methyl Ester Flurbiprofen
pdb|1HT5|B Chain B, The 2.75 Angstrom Resolution Model Of Ovine Cox-1
Complexed With Methyl Ester Flurbiprofen
pdb|1HT8|A Chain A, The 2.7 Angstrom Resolution Model Of Ovine Cox-1
Complexed With Alclofenac
pdb|1HT8|B Chain B, The 2.7 Angstrom Resolution Model Of Ovine Cox-1
Complexed With Alclofenac
Length = 551
Score = 35.8 bits (81), Expect = 0.012, Method: Composition-based stats.
Identities = 18/37 (48%), Positives = 20/37 (54%), Gaps = 2/37 (5%)
Query: 42 VDHCLTDPCLGHGTCINRS-DRYQCLCTPR-YSGNNC 76
V+ C PC G C+ DRYQC CT YSG NC
Sbjct: 1 VNPCCYYPCQHQGICVRFGLDRYQCDCTRTGYSGPNC 37
>pdb|1EBV|A Chain A, Ovine Pghs-1 Complexed With Salicyl Hydroxamic Acid
Length = 551
Score = 35.8 bits (81), Expect = 0.012, Method: Composition-based stats.
Identities = 18/37 (48%), Positives = 20/37 (54%), Gaps = 2/37 (5%)
Query: 42 VDHCLTDPCLGHGTCINRS-DRYQCLCTPR-YSGNNC 76
V+ C PC G C+ DRYQC CT YSG NC
Sbjct: 1 VNPCCYYPCQHQGICVRFGLDRYQCDCTRTGYSGPNC 37
>pdb|1PRH|A Chain A, The X-Ray Crystal Structure Of The Membrane Protein
Prostaglandin H2 Synthase-1
pdb|1PRH|B Chain B, The X-Ray Crystal Structure Of The Membrane Protein
Prostaglandin H2 Synthase-1
Length = 554
Score = 35.8 bits (81), Expect = 0.012, Method: Composition-based stats.
Identities = 18/37 (48%), Positives = 20/37 (54%), Gaps = 2/37 (5%)
Query: 42 VDHCLTDPCLGHGTCINRS-DRYQCLCTPR-YSGNNC 76
V+ C PC G C+ DRYQC CT YSG NC
Sbjct: 1 VNPCCYYPCQHQGICVRFGLDRYQCDCTRTGYSGPNC 37
>pdb|1W0Y|L Chain L, Tf7a_3771 Complex
pdb|1W2K|L Chain L, Tf7a_4380 Complex
Length = 142
Score = 35.8 bits (81), Expect = 0.014, Method: Compositional matrix adjust.
Identities = 16/43 (37%), Positives = 21/43 (48%)
Query: 40 SKVDHCLTDPCLGHGTCINRSDRYQCLCTPRYSGNNCEKDNGD 82
S D C + PC G+C ++ Y C C P + G NCE D
Sbjct: 45 SDGDQCASSPCQNGGSCKDQLQSYICFCLPAFEGRNCETHKDD 87
>pdb|1Z6J|L Chain L, Crystal Structure Of A Ternary Complex Of Factor
Viia/tissue Factor/pyrazinone Inhibitor
pdb|2AER|L Chain L, Crystal Structure Of Benzamidine-Factor ViiaSOLUBLE
TISSUE Factor Complex.
pdb|2FIR|L Chain L, Crystal Structure Of Dfpr-ViiaSTF
pdb|2C4F|L Chain L, Crystal Structure Of Factor Vii.Stf Complexed With
Pd0297121
pdb|2B8O|L Chain L, Crystal Structure Of Glu-gly-arg-chloromethyl
Ketone-factor Viia/soluble Tissue Factor Complex
pdb|2EC9|L Chain L, Crystal Structure Analysis Of Human Factor Viia ,
Souluble Tissue Factor Complexed With Bcx-3607
pdb|3TH2|L Chain L, Mg2+ Is Required For Optimal Folding Of The
Gamma-Carboxyglutamic Acid (Gla) Domains Of Vitamin
K-Dependent Clotting Factors At Physiological Ca2+
pdb|3TH3|L Chain L, Mg2+ Is Required For Optimal Folding Of The
Gamma-Carboxyglutamic Acid (Gla) Domains Of Vitamin
K-Dependent Clotting Factors At Physiological Ca2+
pdb|3TH4|L Chain L, Mg2+ Is Required For Optimal Folding Of The
Gamma-Carboxyglutamic Acid (Gla) Domains Of Vitamin
K-Dependent Clotting Factors At Physiological Ca2+
Length = 142
Score = 35.8 bits (81), Expect = 0.014, Method: Compositional matrix adjust.
Identities = 16/43 (37%), Positives = 21/43 (48%)
Query: 40 SKVDHCLTDPCLGHGTCINRSDRYQCLCTPRYSGNNCEKDNGD 82
S D C + PC G+C ++ Y C C P + G NCE D
Sbjct: 45 SDGDQCASSPCQNGGSCKDQLQSYICFCLPAFEGRNCETHKDD 87
>pdb|1DAN|L Chain L, Complex Of Active Site Inhibited Human Blood Coagulation
Factor Viia With Human Recombinant Soluble Tissue
Factor
pdb|1FAK|L Chain L, Human Tissue Factor Complexed With Coagulation Factor
Viia Inhibited With A Bpti-Mutant
pdb|1WQV|L Chain L, Human Factor Viia-Tissue Factor Complexed With
Propylsulfonamide-D- Thr-Met-P-Aminobenzamidine
pdb|1WSS|L Chain L, Human Factor Viia-Tissue Factor In Complex With Peprid
Mimetic Inhibitor That Has Two Charge Groups In P2 And
P4
pdb|1WTG|L Chain L, Human Factor Viia-Tissue Factor Complexed With
Ethylsulfonamide-D-Biphenylalanine-Gln-P-
Aminobenzamidine
pdb|1WUN|L Chain L, Human Factor Viia-Tissue Factor Complexed With
Ethylsulfonamide-D-Trp-Gln-P-Aminobenzamidine
pdb|1WV7|L Chain L, Human Factor Viia-tissue Factor Complexed With
Ethylsulfonamide-d-5-propoxy-trp-gln-p-aminobenzamidine
pdb|2A2Q|L Chain L, Complex Of Active-Site Inhibited Human Coagulation
Factor Viia With Human Soluble Tissue Factor In The
Presence Of Ca2+, Mg2+, Na+, And Zn2+
pdb|2AEI|L Chain L, Crystal Structure Of A Ternary Complex Of Factor
ViiaTISSUE FACTOR And
2-[[6-[3-(Aminoiminomethyl)phenoxy]-3,
5-Difluro-4-[(1-Methyl-3-
Phenylpropyl)amino]-2-Pyridinyl]oxy]-Benzoic Acid
pdb|2ZP0|L Chain L, Human Factor Viia-Tissue Factor Complexed With
Benzylsulfonamide-D- Ile-Gln-P-Aminobenzamidine
pdb|2ZWL|L Chain L, Human Factor Viia-Tissue Factor Complexed With Highly
Selective Peptide Inhibitor
pdb|2ZZU|L Chain L, Human Factor Viia-Tissue Factor Complexed With
Ethylsulfonamide-D-5-
(3-Carboxybenzyloxy)-Trp-Gln-P-Aminobenzamidine
Length = 152
Score = 35.4 bits (80), Expect = 0.016, Method: Compositional matrix adjust.
Identities = 16/43 (37%), Positives = 21/43 (48%)
Query: 40 SKVDHCLTDPCLGHGTCINRSDRYQCLCTPRYSGNNCEKDNGD 82
S D C + PC G+C ++ Y C C P + G NCE D
Sbjct: 45 SDGDQCASSPCQNGGSCKDQLQSYICFCLPAFEGRNCETHKDD 87
>pdb|1DVA|L Chain L, Crystal Structure Of The Complex Between The Peptide
Exosite Inhibitor E-76 And Coagulation Factor Viia
pdb|1DVA|M Chain M, Crystal Structure Of The Complex Between The Peptide
Exosite Inhibitor E-76 And Coagulation Factor Viia
Length = 101
Score = 35.4 bits (80), Expect = 0.017, Method: Compositional matrix adjust.
Identities = 16/43 (37%), Positives = 21/43 (48%)
Query: 40 SKVDHCLTDPCLGHGTCINRSDRYQCLCTPRYSGNNCEKDNGD 82
S D C + PC G+C ++ Y C C P + G NCE D
Sbjct: 4 SDGDQCASSPCQNGGSCKDQLQSYICFCLPAFEGRNCETHKDD 46
>pdb|4D90|A Chain A, Crystal Structure Of Del-1 Egf Domains
pdb|4D90|B Chain B, Crystal Structure Of Del-1 Egf Domains
Length = 143
Score = 35.4 bits (80), Expect = 0.019, Method: Compositional matrix adjust.
Identities = 35/135 (25%), Positives = 52/135 (38%), Gaps = 31/135 (22%)
Query: 43 DHCLTDPCLGHGTCIN--RSDRYQCLCTPRYSGNNCEK------------DNGDCSSNPC 88
D C +PC G C+ + C C ++ NC G C+ NPC
Sbjct: 1 DICDPNPCENGGICLPGLADGSFSCECPDGFTDPNCSSVVEVASDEEEPTSAGPCTPNPC 60
Query: 89 LNDGVC-VDEVYKGRYW-----ELPE----------IRDCTSNPCLNDCVCVDDGNLSFY 132
N G C + E Y+G + + P I +C PC N +C D ++
Sbjct: 61 HNGGTCEISEAYRGDTFIGYVCKCPRGFNGIHCQHNINECEVEPCKNGGICTDL-VANYS 119
Query: 133 CNCTEDFTGEYCQFE 147
C C +F G CQ++
Sbjct: 120 CECPGEFMGRNCQYK 134
Score = 32.3 bits (72), Expect = 0.17, Method: Compositional matrix adjust.
Identities = 21/66 (31%), Positives = 32/66 (48%), Gaps = 7/66 (10%)
Query: 40 SKVDHCLTDPCLGHGTC-INRSDR------YQCLCTPRYSGNNCEKDNGDCSSNPCLNDG 92
+ C +PC GTC I+ + R Y C C ++G +C+ + +C PC N G
Sbjct: 50 TSAGPCTPNPCHNGGTCEISEAYRGDTFIGYVCKCPRGFNGIHCQHNINECEVEPCKNGG 109
Query: 93 VCVDEV 98
+C D V
Sbjct: 110 ICTDLV 115
Score = 30.4 bits (67), Expect = 0.60, Method: Compositional matrix adjust.
Identities = 29/112 (25%), Positives = 38/112 (33%), Gaps = 31/112 (27%)
Query: 83 CSSNPCLNDGVCVDEVYKGRY-----------------------WELPEIRDCTSNPCLN 119
C NPC N G+C+ + G + E CT NPC N
Sbjct: 3 CDPNPCENGGICLPGLADGSFSCECPDGFTDPNCSSVVEVASDEEEPTSAGPCTPNPCHN 62
Query: 120 DCVC------VDDGNLSFYCNCTEDFTGEYCQFENSAACVTLNPCQNNATCV 165
C D + + C C F G +CQ N C + PC+N C
Sbjct: 63 GGTCEISEAYRGDTFIGYVCKCPRGFNGIHCQ-HNINEC-EVEPCKNGGICT 112
Score = 29.6 bits (65), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 23/67 (34%), Positives = 28/67 (41%), Gaps = 11/67 (16%)
Query: 112 CTSNPCLNDCVCVDD-GNLSFYCNCTEDFTGEYC----------QFENSAACVTLNPCQN 160
C NPC N +C+ + SF C C + FT C + SA T NPC N
Sbjct: 3 CDPNPCENGGICLPGLADGSFSCECPDGFTDPNCSSVVEVASDEEEPTSAGPCTPNPCHN 62
Query: 161 NATCVAS 167
TC S
Sbjct: 63 GGTCEIS 69
Score = 26.6 bits (57), Expect = 7.6, Method: Compositional matrix adjust.
Identities = 11/36 (30%), Positives = 17/36 (47%)
Query: 42 VDHCLTDPCLGHGTCINRSDRYQCLCTPRYSGNNCE 77
++ C +PC G C + Y C C + G NC+
Sbjct: 97 INECEVEPCKNGGICTDLVANYSCECPGEFMGRNCQ 132
>pdb|1J9C|L Chain L, Crystal Structure Of Tissue Factor-Factor Viia Complex
Length = 95
Score = 35.4 bits (80), Expect = 0.019, Method: Compositional matrix adjust.
Identities = 15/40 (37%), Positives = 20/40 (50%)
Query: 43 DHCLTDPCLGHGTCINRSDRYQCLCTPRYSGNNCEKDNGD 82
D C + PC G+C ++ Y C C P + G NCE D
Sbjct: 1 DQCASSPCQNGGSCKDQLQSYICFCLPAFEGRNCETHKDD 40
>pdb|1BF9|A Chain A, N-Terminal Egf-Like Domain From Human Factor Vii, Nmr,
23 Structures
Length = 41
Score = 35.0 bits (79), Expect = 0.023, Method: Compositional matrix adjust.
Identities = 15/38 (39%), Positives = 20/38 (52%)
Query: 40 SKVDHCLTDPCLGHGTCINRSDRYQCLCTPRYSGNNCE 77
S D C + PC G+C ++ Y C C P + G NCE
Sbjct: 1 SDGDQCASSPCQNGGSCKDQLQSYICFCLPAFEGRNCE 38
>pdb|1LMJ|A Chain A, Nmr Study Of The Fibrillin-1 Cbegf12-13 Pair Of Ca2+
Binding Epidermal Growth Factor-like Domains
Length = 86
Score = 34.7 bits (78), Expect = 0.028, Method: Compositional matrix adjust.
Identities = 25/76 (32%), Positives = 31/76 (40%), Gaps = 18/76 (23%)
Query: 15 DINECETVKDVCNYGICVNTNGNGNSK-----------------VDHCLTDPCL-GHGTC 56
DI+EC D+C G CVNT G+ K +D C DP L G C
Sbjct: 2 DIDECRISPDLCGRGQCVNTPGDFECKCDEGYESGFMMMKNCMDIDECQRDPLLCRGGVC 61
Query: 57 INRSDRYQCLCTPRYS 72
N Y+C C P +
Sbjct: 62 HNTEGSYRCECPPGHQ 77
>pdb|3QH0|A Chain A, X-Ray Crystal Structure Of Palmitic Acid Bound To The
Cyclooxygenase Channel Of Cyclooxygenase-2
pdb|3QH0|B Chain B, X-Ray Crystal Structure Of Palmitic Acid Bound To The
Cyclooxygenase Channel Of Cyclooxygenase-2
pdb|3QMO|A Chain A, X-Ray Crystal Structure Of Ns-398 Bound To The
Cyclooxygenase Channel Of Cyclooxygenase-2
pdb|3QMO|B Chain B, X-Ray Crystal Structure Of Ns-398 Bound To The
Cyclooxygenase Channel Of Cyclooxygenase-2
pdb|4E1G|A Chain A, X-Ray Crystal Structure Of Alpha-Linolenic Acid Bound To
The Cyclooxygenase Channel Of Cyclooxygenase-2
pdb|4E1G|B Chain B, X-Ray Crystal Structure Of Alpha-Linolenic Acid Bound To
The Cyclooxygenase Channel Of Cyclooxygenase-2
Length = 610
Score = 34.3 bits (77), Expect = 0.041, Method: Composition-based stats.
Identities = 15/34 (44%), Positives = 18/34 (52%), Gaps = 1/34 (2%)
Query: 112 CTSNPCLNDCVCVDDGNLSFYCNCTED-FTGEYC 144
C SNPC N C+ G + C+CT F GE C
Sbjct: 27 CCSNPCQNRGECMSTGFDQYKCDCTRTGFYGENC 60
>pdb|3KRK|A Chain A, X-Ray Crystal Structure Of Arachidonic Acid Bound In The
Cyclooxygenase Channel Of L531f Murine Cox-2
pdb|3KRK|B Chain B, X-Ray Crystal Structure Of Arachidonic Acid Bound In The
Cyclooxygenase Channel Of L531f Murine Cox-2
Length = 591
Score = 34.3 bits (77), Expect = 0.042, Method: Composition-based stats.
Identities = 15/34 (44%), Positives = 18/34 (52%), Gaps = 1/34 (2%)
Query: 112 CTSNPCLNDCVCVDDGNLSFYCNCTED-FTGEYC 144
C SNPC N C+ G + C+CT F GE C
Sbjct: 8 CCSNPCQNRGECMSTGFDQYKCDCTRTGFYGENC 41
>pdb|3HS5|A Chain A, X-Ray Crystal Structure Of Arachidonic Acid Bound To The
Cyclooxygenase Channel Of Cyclooxygenase-2
pdb|3HS5|B Chain B, X-Ray Crystal Structure Of Arachidonic Acid Bound To The
Cyclooxygenase Channel Of Cyclooxygenase-2
pdb|3HS6|A Chain A, X-Ray Crystal Structure Of Eicosapentaenoic Acid Bound To
The Cyclooxygenase Channel Of Cyclooxygenase-2
pdb|3HS6|B Chain B, X-Ray Crystal Structure Of Eicosapentaenoic Acid Bound To
The Cyclooxygenase Channel Of Cyclooxygenase-2
pdb|3HS7|A Chain A, X-Ray Crystal Structure Of Docosahexaenoic Acid Bound To
The Cyclooxygenase Channel Of Cyclooxygenase-2
pdb|3HS7|B Chain B, X-Ray Crystal Structure Of Docosahexaenoic Acid Bound To
The Cyclooxygenase Channel Of Cyclooxygenase-2
Length = 591
Score = 34.3 bits (77), Expect = 0.042, Method: Composition-based stats.
Identities = 15/34 (44%), Positives = 18/34 (52%), Gaps = 1/34 (2%)
Query: 112 CTSNPCLNDCVCVDDGNLSFYCNCTED-FTGEYC 144
C SNPC N C+ G + C+CT F GE C
Sbjct: 8 CCSNPCQNRGECMSTGFDQYKCDCTRTGFYGENC 41
>pdb|3TZI|A Chain A, X-Ray Crystal Structure Of Arachidonic Acid Bound In The
Cyclooxygenase Channel Of G533v Murine Cox-2
pdb|3TZI|B Chain B, X-Ray Crystal Structure Of Arachidonic Acid Bound In The
Cyclooxygenase Channel Of G533v Murine Cox-2
Length = 593
Score = 34.3 bits (77), Expect = 0.043, Method: Composition-based stats.
Identities = 15/34 (44%), Positives = 18/34 (52%), Gaps = 1/34 (2%)
Query: 112 CTSNPCLNDCVCVDDGNLSFYCNCTED-FTGEYC 144
C SNPC N C+ G + C+CT F GE C
Sbjct: 10 CCSNPCQNRGECMSTGFDQYKCDCTRTGFYGENC 43
>pdb|1PXX|A Chain A, Crystal Structure Of Diclofenac Bound To The
Cyclooxygenase Active Site Of Cox-2
pdb|1PXX|B Chain B, Crystal Structure Of Diclofenac Bound To The
Cyclooxygenase Active Site Of Cox-2
pdb|1PXX|C Chain C, Crystal Structure Of Diclofenac Bound To The
Cyclooxygenase Active Site Of Cox-2
pdb|1PXX|D Chain D, Crystal Structure Of Diclofenac Bound To The
Cyclooxygenase Active Site Of Cox-2
pdb|4FM5|A Chain A, X-Ray Structure Of Des-Methylflurbiprofen Bound To Murine
Cox-2
pdb|4FM5|B Chain B, X-Ray Structure Of Des-Methylflurbiprofen Bound To Murine
Cox-2
pdb|4FM5|C Chain C, X-Ray Structure Of Des-Methylflurbiprofen Bound To Murine
Cox-2
pdb|4FM5|D Chain D, X-Ray Structure Of Des-Methylflurbiprofen Bound To Murine
Cox-2
Length = 604
Score = 34.3 bits (77), Expect = 0.044, Method: Composition-based stats.
Identities = 15/34 (44%), Positives = 18/34 (52%), Gaps = 1/34 (2%)
Query: 112 CTSNPCLNDCVCVDDGNLSFYCNCTED-FTGEYC 144
C SNPC N C+ G + C+CT F GE C
Sbjct: 21 CCSNPCQNRGECMSTGFDQYKCDCTRTGFYGENC 54
>pdb|1DDX|A Chain A, Crystal Structure Of A Mixture Of Arachidonic Acid And
Prostaglandin Bound To The Cyclooxygenase Active Site Of
Cox-2: Prostaglandin Structure
pdb|1DDX|B Chain B, Crystal Structure Of A Mixture Of Arachidonic Acid And
Prostaglandin Bound To The Cyclooxygenase Active Site Of
Cox-2: Prostaglandin Structure
pdb|1DDX|C Chain C, Crystal Structure Of A Mixture Of Arachidonic Acid And
Prostaglandin Bound To The Cyclooxygenase Active Site Of
Cox-2: Prostaglandin Structure
pdb|1DDX|D Chain D, Crystal Structure Of A Mixture Of Arachidonic Acid And
Prostaglandin Bound To The Cyclooxygenase Active Site Of
Cox-2: Prostaglandin Structure
pdb|3NTG|A Chain A, Crystal Structure Of Cox-2 With Selective Compound 23d-(R)
pdb|3NTG|B Chain B, Crystal Structure Of Cox-2 With Selective Compound 23d-(R)
pdb|3NTG|C Chain C, Crystal Structure Of Cox-2 With Selective Compound 23d-(R)
pdb|3NTG|D Chain D, Crystal Structure Of Cox-2 With Selective Compound 23d-(R)
Length = 552
Score = 34.3 bits (77), Expect = 0.044, Method: Composition-based stats.
Identities = 15/34 (44%), Positives = 18/34 (52%), Gaps = 1/34 (2%)
Query: 112 CTSNPCLNDCVCVDDGNLSFYCNCTED-FTGEYC 144
C SNPC N C+ G + C+CT F GE C
Sbjct: 4 CCSNPCQNRGECMSTGFDQYKCDCTRTGFYGENC 37
>pdb|1CVU|A Chain A, Crystal Structure Of Arachidonic Acid Bound To The
Cyclooxygenase Active Site Of Cox-2
pdb|1CVU|B Chain B, Crystal Structure Of Arachidonic Acid Bound To The
Cyclooxygenase Active Site Of Cox-2
Length = 552
Score = 34.3 bits (77), Expect = 0.044, Method: Composition-based stats.
Identities = 15/34 (44%), Positives = 18/34 (52%), Gaps = 1/34 (2%)
Query: 112 CTSNPCLNDCVCVDDGNLSFYCNCTED-FTGEYC 144
C SNPC N C+ G + C+CT F GE C
Sbjct: 4 CCSNPCQNRGECMSTGFDQYKCDCTRTGFYGENC 37
>pdb|3OLT|A Chain A, X-Ray Crystal Structure Of Arachidonic Acid Bound To The
Cyclooxygenase Channel Of R513h Murine Cox-2
pdb|3OLT|B Chain B, X-Ray Crystal Structure Of Arachidonic Acid Bound To The
Cyclooxygenase Channel Of R513h Murine Cox-2
pdb|3OLU|A Chain A, X-Ray Crystal Structure Of 1-Arachidonoyl Glycerol Bound
To The Cyclooxygenase Channel Of R513h Murine Cox-2
pdb|3OLU|B Chain B, X-Ray Crystal Structure Of 1-Arachidonoyl Glycerol Bound
To The Cyclooxygenase Channel Of R513h Murine Cox-2
Length = 592
Score = 34.3 bits (77), Expect = 0.044, Method: Composition-based stats.
Identities = 15/34 (44%), Positives = 18/34 (52%), Gaps = 1/34 (2%)
Query: 112 CTSNPCLNDCVCVDDGNLSFYCNCTED-FTGEYC 144
C SNPC N C+ G + C+CT F GE C
Sbjct: 9 CCSNPCQNRGECMSTGFDQYKCDCTRTGFYGENC 42
>pdb|3MDL|A Chain A, X-Ray Crystal Structure Of 1-Arachidonoyl Glycerol Bound
To The Cyclooxygenase Channel Of Cyclooxygenase-2
pdb|3MDL|B Chain B, X-Ray Crystal Structure Of 1-Arachidonoyl Glycerol Bound
To The Cyclooxygenase Channel Of Cyclooxygenase-2
Length = 587
Score = 34.3 bits (77), Expect = 0.044, Method: Composition-based stats.
Identities = 15/34 (44%), Positives = 18/34 (52%), Gaps = 1/34 (2%)
Query: 112 CTSNPCLNDCVCVDDGNLSFYCNCTED-FTGEYC 144
C SNPC N C+ G + C+CT F GE C
Sbjct: 9 CCSNPCQNRGECMSTGFDQYKCDCTRTGFYGENC 42
>pdb|3NT1|A Chain A, High Resolution Structure Of Naproxen:cox-2 Complex.
pdb|3NT1|B Chain B, High Resolution Structure Of Naproxen:cox-2 Complex.
pdb|3NTB|A Chain A, Structure Of 6-Methylthio Naproxen Analog Bound To Mcox-2.
pdb|3NTB|B Chain B, Structure Of 6-Methylthio Naproxen Analog Bound To Mcox-2.
pdb|3NTB|C Chain C, Structure Of 6-Methylthio Naproxen Analog Bound To Mcox-2.
pdb|3NTB|D Chain D, Structure Of 6-Methylthio Naproxen Analog Bound To Mcox-2.
pdb|3LN0|A Chain A, Structure Of Compound 5c-S Bound At The Active Site Of
Cox-2
pdb|3LN0|B Chain B, Structure Of Compound 5c-S Bound At The Active Site Of
Cox-2
pdb|3LN0|C Chain C, Structure Of Compound 5c-S Bound At The Active Site Of
Cox-2
pdb|3LN0|D Chain D, Structure Of Compound 5c-S Bound At The Active Site Of
Cox-2
pdb|3LN1|A Chain A, Structure Of Celecoxib Bound At The Cox-2 Active Site
pdb|3LN1|B Chain B, Structure Of Celecoxib Bound At The Cox-2 Active Site
pdb|3LN1|C Chain C, Structure Of Celecoxib Bound At The Cox-2 Active Site
pdb|3LN1|D Chain D, Structure Of Celecoxib Bound At The Cox-2 Active Site
pdb|3MQE|A Chain A, Structure Of Sc-75416 Bound At The Cox-2 Active Site
pdb|3MQE|B Chain B, Structure Of Sc-75416 Bound At The Cox-2 Active Site
pdb|3MQE|C Chain C, Structure Of Sc-75416 Bound At The Cox-2 Active Site
pdb|3MQE|D Chain D, Structure Of Sc-75416 Bound At The Cox-2 Active Site
pdb|3Q7D|A Chain A, Structure Of (R)-Naproxen Bound To Mcox-2.
pdb|3Q7D|B Chain B, Structure Of (R)-Naproxen Bound To Mcox-2
Length = 587
Score = 34.3 bits (77), Expect = 0.044, Method: Composition-based stats.
Identities = 15/34 (44%), Positives = 18/34 (52%), Gaps = 1/34 (2%)
Query: 112 CTSNPCLNDCVCVDDGNLSFYCNCTED-FTGEYC 144
C SNPC N C+ G + C+CT F GE C
Sbjct: 4 CCSNPCQNRGECMSTGFDQYKCDCTRTGFYGENC 37
>pdb|3PGH|A Chain A, Cyclooxygenase-2 (Prostaglandin Synthase-2) Complexed With
A Non- Selective Inhibitor, Flurbiprofen
pdb|3PGH|B Chain B, Cyclooxygenase-2 (Prostaglandin Synthase-2) Complexed With
A Non- Selective Inhibitor, Flurbiprofen
pdb|3PGH|C Chain C, Cyclooxygenase-2 (Prostaglandin Synthase-2) Complexed With
A Non- Selective Inhibitor, Flurbiprofen
pdb|3PGH|D Chain D, Cyclooxygenase-2 (Prostaglandin Synthase-2) Complexed With
A Non- Selective Inhibitor, Flurbiprofen
pdb|4COX|A Chain A, Cyclooxygenase-2 (Prostaglandin Synthase-2) Complexed With
A Non- Selective Inhibitor, Indomethacin
pdb|4COX|B Chain B, Cyclooxygenase-2 (Prostaglandin Synthase-2) Complexed With
A Non- Selective Inhibitor, Indomethacin
pdb|4COX|C Chain C, Cyclooxygenase-2 (Prostaglandin Synthase-2) Complexed With
A Non- Selective Inhibitor, Indomethacin
pdb|4COX|D Chain D, Cyclooxygenase-2 (Prostaglandin Synthase-2) Complexed With
A Non- Selective Inhibitor, Indomethacin
pdb|5COX|A Chain A, Uninhibited Mouse Cyclooxygenase-2 (Prostaglandin
Synthase-2)
pdb|5COX|B Chain B, Uninhibited Mouse Cyclooxygenase-2 (Prostaglandin
Synthase-2)
pdb|5COX|C Chain C, Uninhibited Mouse Cyclooxygenase-2 (Prostaglandin
Synthase-2)
pdb|5COX|D Chain D, Uninhibited Mouse Cyclooxygenase-2 (Prostaglandin
Synthase-2)
pdb|6COX|A Chain A, Cyclooxygenase-2 (Prostaglandin Synthase-2) Complexed With
A Selective Inhibitor, Sc-558 In I222 Space Group
pdb|6COX|B Chain B, Cyclooxygenase-2 (Prostaglandin Synthase-2) Complexed With
A Selective Inhibitor, Sc-558 In I222 Space Group
pdb|1CX2|A Chain A, Cyclooxygenase-2 (Prostaglandin Synthase-2) Complexed With
A Selective Inhibitor, Sc-558
pdb|1CX2|B Chain B, Cyclooxygenase-2 (Prostaglandin Synthase-2) Complexed With
A Selective Inhibitor, Sc-558
pdb|1CX2|C Chain C, Cyclooxygenase-2 (Prostaglandin Synthase-2) Complexed With
A Selective Inhibitor, Sc-558
pdb|1CX2|D Chain D, Cyclooxygenase-2 (Prostaglandin Synthase-2) Complexed With
A Selective Inhibitor, Sc-558
Length = 587
Score = 34.3 bits (77), Expect = 0.044, Method: Composition-based stats.
Identities = 15/34 (44%), Positives = 18/34 (52%), Gaps = 1/34 (2%)
Query: 112 CTSNPCLNDCVCVDDGNLSFYCNCTED-FTGEYC 144
C SNPC N C+ G + C+CT F GE C
Sbjct: 4 CCSNPCQNRGECMSTGFDQYKCDCTRTGFYGENC 37
>pdb|3RR3|A Chain A, Structure Of (R)-Flurbiprofen Bound To Mcox-2
pdb|3RR3|B Chain B, Structure Of (R)-Flurbiprofen Bound To Mcox-2
pdb|3RR3|C Chain C, Structure Of (R)-Flurbiprofen Bound To Mcox-2
pdb|3RR3|D Chain D, Structure Of (R)-Flurbiprofen Bound To Mcox-2
Length = 560
Score = 33.9 bits (76), Expect = 0.048, Method: Composition-based stats.
Identities = 15/34 (44%), Positives = 18/34 (52%), Gaps = 1/34 (2%)
Query: 112 CTSNPCLNDCVCVDDGNLSFYCNCTED-FTGEYC 144
C SNPC N C+ G + C+CT F GE C
Sbjct: 4 CCSNPCQNRGECMSTGFDQYKCDCTRTGFYGENC 37
>pdb|1EZQ|B Chain B, Crystal Structure Of Human Coagulation Factor Xa
Complexed With Rpr128515
pdb|1F0R|B Chain B, Crystal Structure Of Human Coagulation Factor Xa
Complexed With Rpr208815
pdb|1F0S|B Chain B, Crystal Structure Of Human Coagulation Factor Xa
Complexed With Rpr208707
pdb|1KSN|B Chain B, Crystal Structure Of Human Coagulation Factor Xa
Complexed With Fxv673
pdb|1NFW|B Chain B, Crystal Structure Of Human Coagulation Factor Xa
Complexed With Rpr209685
pdb|1NFX|B Chain B, Crystal Structure Of Human Coagulation Factor Xa
Complexed With Rpr208944
pdb|1NFY|B Chain B, Crystal Structure Of Human Coagulation Factor Xa
Complexed With Rpr200095
pdb|1LPG|A Chain A, Crystal Structure Of Fxa In Complex With 79.
pdb|1LPK|A Chain A, Crystal Structure Of Fxa In Complex With 125.
pdb|1LPZ|A Chain A, Crystal Structure Of Fxa In Complex With 41.
pdb|1LQD|A Chain A, Crystal Structure Of Fxa In Complex With 45.
pdb|2BOH|A Chain A, Crystal Structure Of Factor Xa In Complex With Compound
"1"
pdb|2CJI|B Chain B, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J2U|B Chain B, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J34|B Chain B, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J38|B Chain B, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J4I|B Chain B, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J94|B Chain B, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J95|B Chain B, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2UWL|B Chain B, Selective And Dual Action Orally Active Inhibitors Of
Thrombin And Factor Xa
pdb|2UWO|B Chain B, Selective And Dual Action Orally Active Inhibitors Of
Thrombin And Factor Xa
pdb|2UWP|B Chain B, Factor Xa Inhibitor Complex
pdb|2VH0|B Chain B, Structure And Property Based Design Of Factor Xa
Inhibitors: Biaryl Pyrrolidin-2-Ones Incorporating
Basic Heterocyclic Motifs
pdb|2VH6|B Chain B, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Biaryl P4 Motifs
pdb|2WYG|B Chain B, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Monoaryl P4 Motifs
pdb|2WYJ|B Chain B, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Monoaryl P4 Motifs
pdb|2Y7X|B Chain B, The Discovery Of Potent And Long-Acting Oral Factor Xa
Inhibitors With Tetrahydroisoquinoline And Benzazepine
P4 Motifs
pdb|2Y7Z|B Chain B, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|2Y80|B Chain B, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|2Y81|B Chain B, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|2Y82|B Chain B, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
Length = 134
Score = 33.9 bits (76), Expect = 0.052, Method: Compositional matrix adjust.
Identities = 26/89 (29%), Positives = 31/89 (34%), Gaps = 8/89 (8%)
Query: 3 FKPISLSTLCESDINECETVKDVCNYGICVNTNGNGNSKVDHCLTDPCLGHGTCINRSDR 62
K L C + E ++V N N D C T PC G C +
Sbjct: 3 MKKGHLERECMEETCSYEEAREVFEDSDKTNEFWNKYKDGDQCETSPCQNQGKCKDGLGE 62
Query: 63 YQCLCTPRYSGNNCE--------KDNGDC 83
Y C C + G NCE DNGDC
Sbjct: 63 YTCTCLEGFEGKNCELFTRKLCSLDNGDC 91
Score = 26.2 bits (56), Expect = 9.8, Method: Compositional matrix adjust.
Identities = 25/90 (27%), Positives = 39/90 (43%), Gaps = 15/90 (16%)
Query: 78 KDNGDCSSNPCLNDGVCVD----------EVYKGRYWELPEIRDCTSNPCLNDCVCVDDG 127
KD C ++PC N G C D E ++G+ EL + C+ + D C ++
Sbjct: 40 KDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQFCHEEQ 99
Query: 128 NLSFYCNCTEDFTGEYCQFENSAACVTLNP 157
N S C+C +T +N AC+ P
Sbjct: 100 N-SVVCSCARGYT----LADNGKACIPTGP 124
>pdb|1EDM|B Chain B, Epidermal Growth Factor-Like Domain From Human Factor Ix
pdb|1EDM|C Chain C, Epidermal Growth Factor-Like Domain From Human Factor Ix
pdb|1IXA|A Chain A, The Three-Dimensional Structure Of The First Egf-Like
Module Of Human Factor Ix: Comparison With Egf And
Tgf-A
Length = 39
Score = 33.5 bits (75), Expect = 0.069, Method: Compositional matrix adjust.
Identities = 14/35 (40%), Positives = 21/35 (60%)
Query: 43 DHCLTDPCLGHGTCINRSDRYQCLCTPRYSGNNCE 77
D C ++PCL G+C + + Y+C C + G NCE
Sbjct: 4 DQCESNPCLNGGSCKDDINSYECWCPFGFEGKNCE 38
Score = 28.1 bits (61), Expect = 2.7, Method: Compositional matrix adjust.
Identities = 17/35 (48%), Positives = 20/35 (57%), Gaps = 1/35 (2%)
Query: 112 CTSNPCLNDCVCVDDGNLSFYCNCTEDFTGEYCQF 146
C SNPCLN C DD N S+ C C F G+ C+
Sbjct: 6 CESNPCLNGGSCKDDIN-SYECWCPFGFEGKNCEL 39
Score = 26.2 bits (56), Expect = 9.9, Method: Compositional matrix adjust.
Identities = 12/26 (46%), Positives = 14/26 (53%)
Query: 79 DNGDCSSNPCLNDGVCVDEVYKGRYW 104
D C SNPCLN G C D++ W
Sbjct: 2 DGDQCESNPCLNGGSCKDDINSYECW 27
>pdb|1NFU|B Chain B, Crystal Structure Of Human Coagulation Factor Xa
Complexed With Rpr132747
Length = 195
Score = 33.5 bits (75), Expect = 0.074, Method: Compositional matrix adjust.
Identities = 23/72 (31%), Positives = 27/72 (37%), Gaps = 8/72 (11%)
Query: 20 ETVKDVCNYGICVNTNGNGNSKVDHCLTDPCLGHGTCINRSDRYQCLCTPRYSGNNCE-- 77
E ++V N N D C T PC G C + Y C C + G NCE
Sbjct: 20 EEAREVFEDSDKTNEFWNKYKDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELF 79
Query: 78 ------KDNGDC 83
DNGDC
Sbjct: 80 TRKLCSLDNGDC 91
>pdb|2PUQ|L Chain L, Crystal Structure Of Active Site Inhibited Coagulation
Factor Viia In Complex With Soluble Tissue Factor
Length = 94
Score = 33.5 bits (75), Expect = 0.075, Method: Compositional matrix adjust.
Identities = 14/39 (35%), Positives = 19/39 (48%)
Query: 44 HCLTDPCLGHGTCINRSDRYQCLCTPRYSGNNCEKDNGD 82
C + PC G+C ++ Y C C P + G NCE D
Sbjct: 1 QCASSPCQNGGSCKDQLQSYICFCLPAFEGRNCETHKDD 39
>pdb|2VJ2|A Chain A, Human Jagged-1, Domains Dsl And Egfs1-3
pdb|2VJ2|B Chain B, Human Jagged-1, Domains Dsl And Egfs1-3
Length = 169
Score = 33.1 bits (74), Expect = 0.084, Method: Compositional matrix adjust.
Identities = 27/104 (25%), Positives = 39/104 (37%), Gaps = 31/104 (29%)
Query: 43 DHCLTDPCLGHGTCINRSDRYQCLCTPRYSGNNCEKDNGDCSSNPCLNDGVCVDEVYKGR 102
D C+ P HG C ++ +QCLC + G C+KD C
Sbjct: 97 DKCIPHPGCVHGIC---NEPWQCLCETNWGGQLCDKDLNYCG------------------ 135
Query: 103 YWELPEIRDCTSNPCLNDCVCVDDGNLSFYCNCTEDFTGEYCQF 146
T PCLN C + G + C+C E ++G C+
Sbjct: 136 ----------THQPCLNGGTCSNTGPDKYQCSCPEGYSGPNCEI 169
Score = 30.8 bits (68), Expect = 0.46, Method: Compositional matrix adjust.
Identities = 24/70 (34%), Positives = 28/70 (40%), Gaps = 26/70 (37%)
Query: 9 STLCESDINECETVKDVCNYGICVNTNGNGNSKVDHCLTDPCLGHGTCINRS-DRYQCLC 67
LC+ D+N C T + PCL GTC N D+YQC C
Sbjct: 124 GQLCDKDLNYCGTHQ-------------------------PCLNGGTCSNTGPDKYQCSC 158
Query: 68 TPRYSGNNCE 77
YSG NCE
Sbjct: 159 PEGYSGPNCE 168
>pdb|1X7A|L Chain L, Porcine Factor Ixa Complexed To 1-{3-[amino(Imino)
Methyl]phenyl}-N-[4-(1h-Benzimidazol-1-Yl)-2-
Fluorophenyl]-
3-(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide
Length = 146
Score = 33.1 bits (74), Expect = 0.088, Method: Compositional matrix adjust.
Identities = 15/37 (40%), Positives = 20/37 (54%)
Query: 43 DHCLTDPCLGHGTCINRSDRYQCLCTPRYSGNNCEKD 79
D C +PCL G C + + Y+C C + G NCE D
Sbjct: 49 DQCEPNPCLNGGLCKDDINSYECWCQVGFEGKNCELD 85
Score = 26.6 bits (57), Expect = 8.4, Method: Compositional matrix adjust.
Identities = 11/26 (42%), Positives = 14/26 (53%)
Query: 79 DNGDCSSNPCLNDGVCVDEVYKGRYW 104
D C NPCLN G+C D++ W
Sbjct: 47 DGDQCEPNPCLNGGLCKDDINSYECW 72
>pdb|1QFK|L Chain L, Structure Of Human Factor Viia And Its Implications For
The Triggering Of Blood Coagulation
Length = 104
Score = 33.1 bits (74), Expect = 0.092, Method: Compositional matrix adjust.
Identities = 14/39 (35%), Positives = 19/39 (48%)
Query: 44 HCLTDPCLGHGTCINRSDRYQCLCTPRYSGNNCEKDNGD 82
C + PC G+C ++ Y C C P + G NCE D
Sbjct: 1 QCASSPCQNGGSCKDQLQSYICFCLPAFEGRNCETHKDD 39
>pdb|1P0S|L Chain L, Crystal Structure Of Blood Coagulation Factor Xa In
Complex With Ecotin M84r
Length = 138
Score = 32.7 bits (73), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 19/49 (38%), Positives = 21/49 (42%), Gaps = 8/49 (16%)
Query: 43 DHCLTDPCLGHGTCINRSDRYQCLCTPRYSGNNCE--------KDNGDC 83
D C T PC G C + Y C C + G NCE DNGDC
Sbjct: 48 DQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDC 96
Score = 26.6 bits (57), Expect = 8.8, Method: Compositional matrix adjust.
Identities = 25/90 (27%), Positives = 39/90 (43%), Gaps = 15/90 (16%)
Query: 78 KDNGDCSSNPCLNDGVCVD----------EVYKGRYWELPEIRDCTSNPCLNDCVCVDDG 127
KD C ++PC N G C D E ++G+ EL + C+ + D C ++
Sbjct: 45 KDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQFCHEEQ 104
Query: 128 NLSFYCNCTEDFTGEYCQFENSAACVTLNP 157
N S C+C +T +N AC+ P
Sbjct: 105 N-SVVCSCARGYT----LADNGKACIPTGP 129
>pdb|3ENS|A Chain A, Crystal Structure Of Human Fxa In Complex With Methyl
(2z)-3-[(3-
Chloro-1h-indol-7-yl)amino]-2-cyano-3-{[(3s)-2-oxo-1-
(2-oxo-2-
Pyrrolidin-1-ylethyl)azepan-3-yl]amino}acrylate
pdb|3ENS|C Chain C, Crystal Structure Of Human Fxa In Complex With Methyl
(2z)-3-[(3-
Chloro-1h-indol-7-yl)amino]-2-cyano-3-{[(3s)-2-oxo-1-
(2-oxo-2-
Pyrrolidin-1-ylethyl)azepan-3-yl]amino}acrylate
pdb|3HPT|A Chain A, Crystal Structure Of Human Fxa In Complex With
(S)-2-Cyano-1-(2-
Methylbenzofuran-5-Yl)-3-(2-Oxo-1-(2-Oxo-2-(Pyrrolidin-
1-Yl)ethyl) Azepan-3-Yl)guanidine
pdb|3HPT|C Chain C, Crystal Structure Of Human Fxa In Complex With
(S)-2-Cyano-1-(2-
Methylbenzofuran-5-Yl)-3-(2-Oxo-1-(2-Oxo-2-(Pyrrolidin-
1-Yl)ethyl) Azepan-3-Yl)guanidine
pdb|3K9X|A Chain A, X-Ray Crystal Structure Of Human Fxa In Complex With
(S)-N-((2-
Methylbenzofuran-5-Ylamino)(2-Oxo-1-(2-Oxo-2-
(Pyrrolidin-1-Yl) Ethyl)azepan-3-
Ylamino)methylene)nicotinamide
pdb|3K9X|C Chain C, X-Ray Crystal Structure Of Human Fxa In Complex With
(S)-N-((2-
Methylbenzofuran-5-Ylamino)(2-Oxo-1-(2-Oxo-2-
(Pyrrolidin-1-Yl) Ethyl)azepan-3-
Ylamino)methylene)nicotinamide
pdb|3SW2|A Chain A, X-Ray Crystal Structure Of Human Fxa In Complex With
6-Chloro-N-((3s)-
2-Oxo-1-(2-Oxo-2-((5s)-8-Oxo-5,6-Dihydro-1h-1,
5-Methanopyrido[1,2-
A][1,5]diazocin-3(2h,4h,
8h)-Yl)ethyl)piperidin-3-Yl)naphthalene-2- Sulfonamide
Length = 94
Score = 32.3 bits (72), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 19/49 (38%), Positives = 21/49 (42%), Gaps = 8/49 (16%)
Query: 43 DHCLTDPCLGHGTCINRSDRYQCLCTPRYSGNNCE--------KDNGDC 83
D C T PC G C + Y C C + G NCE DNGDC
Sbjct: 4 DQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDC 52
Score = 26.9 bits (58), Expect = 6.0, Method: Compositional matrix adjust.
Identities = 25/90 (27%), Positives = 39/90 (43%), Gaps = 15/90 (16%)
Query: 78 KDNGDCSSNPCLNDGVCVD----------EVYKGRYWELPEIRDCTSNPCLNDCVCVDDG 127
KD C ++PC N G C D E ++G+ EL + C+ + D C ++
Sbjct: 1 KDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQFCHEEQ 60
Query: 128 NLSFYCNCTEDFTGEYCQFENSAACVTLNP 157
N S C+C +T +N AC+ P
Sbjct: 61 N-SVVCSCARGYT----LADNGKACIPTGP 85
>pdb|1FAX|L Chain L, Coagulation Factor Xa Inhibitor Complex
Length = 96
Score = 32.3 bits (72), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 19/49 (38%), Positives = 21/49 (42%), Gaps = 8/49 (16%)
Query: 43 DHCLTDPCLGHGTCINRSDRYQCLCTPRYSGNNCE--------KDNGDC 83
D C T PC G C + Y C C + G NCE DNGDC
Sbjct: 5 DQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDC 53
>pdb|1IOE|L Chain L, Human Coagulation Factor Xa In Complex With M55532
pdb|1IQE|L Chain L, Human Coagulation Factor Xa In Complex With M55590
pdb|1IQF|L Chain L, Human Coagulation Factor Xa In Complex With M55165
pdb|1IQG|L Chain L, Human Coagulation Factor Xa In Complex With M55159
pdb|1IQH|L Chain L, Human Coagulation Factor Xa In Complex With M55143
pdb|1IQI|L Chain L, Human Coagulation Factor Xa In Complex With M55125
pdb|1IQJ|L Chain L, Human Coagulation Factor Xa In Complex With M55124
pdb|1IQK|L Chain L, Human Coagulation Factor Xa In Complex With M55113
pdb|1IQL|L Chain L, Human Coagulation Factor Xa In Complex With M54476
pdb|1IQM|L Chain L, Human Coagulation Factor Xa In Complex With M54471
pdb|1IQN|L Chain L, Human Coagulation Factor Xa In Complex With M55192
pdb|1C5M|F Chain F, Structural Basis For Selectivity Of A Small Molecule,
S1- Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|4A7I|A Chain A, Factor Xa In Complex With A Potent 2-Amino-Ethane
Sulfonamide Inhibitor
Length = 96
Score = 32.3 bits (72), Expect = 0.15, Method: Compositional matrix adjust.
Identities = 19/49 (38%), Positives = 21/49 (42%), Gaps = 8/49 (16%)
Query: 43 DHCLTDPCLGHGTCINRSDRYQCLCTPRYSGNNCE--------KDNGDC 83
D C T PC G C + Y C C + G NCE DNGDC
Sbjct: 5 DQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDC 53
Score = 26.9 bits (58), Expect = 5.9, Method: Compositional matrix adjust.
Identities = 25/90 (27%), Positives = 39/90 (43%), Gaps = 15/90 (16%)
Query: 78 KDNGDCSSNPCLNDGVCVD----------EVYKGRYWELPEIRDCTSNPCLNDCVCVDDG 127
KD C ++PC N G C D E ++G+ EL + C+ + D C ++
Sbjct: 2 KDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQFCHEEQ 61
Query: 128 NLSFYCNCTEDFTGEYCQFENSAACVTLNP 157
N S C+C +T +N AC+ P
Sbjct: 62 N-SVVCSCARGYT----LADNGKACIPTGP 86
>pdb|2H9E|L Chain L, Crystal Structure Of FxaSELECTIDENAPC2 TERNARY COMPLEX
Length = 149
Score = 32.3 bits (72), Expect = 0.15, Method: Compositional matrix adjust.
Identities = 19/49 (38%), Positives = 21/49 (42%), Gaps = 8/49 (16%)
Query: 43 DHCLTDPCLGHGTCINRSDRYQCLCTPRYSGNNCE--------KDNGDC 83
D C T PC G C + Y C C + G NCE DNGDC
Sbjct: 3 DQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDC 51
>pdb|1G2L|B Chain B, Factor Xa Inhibitor Complex
pdb|1G2M|B Chain B, Factor Xa Inhibitor Complex
Length = 94
Score = 32.3 bits (72), Expect = 0.15, Method: Compositional matrix adjust.
Identities = 19/49 (38%), Positives = 21/49 (42%), Gaps = 8/49 (16%)
Query: 43 DHCLTDPCLGHGTCINRSDRYQCLCTPRYSGNNCE--------KDNGDC 83
D C T PC G C + Y C C + G NCE DNGDC
Sbjct: 3 DQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDC 51
>pdb|1ESL|A Chain A, Insight Into E-Selectin(Slash)ligand Interaction From The
Crystal Structure And Mutagenesis Of The Lec(Slash)egf
Domains
Length = 162
Score = 32.3 bits (72), Expect = 0.17, Method: Compositional matrix adjust.
Identities = 14/34 (41%), Positives = 18/34 (52%)
Query: 45 CLTDPCLGHGTCINRSDRYQCLCTPRYSGNNCEK 78
C C GHG C+ + Y C C P +SG CE+
Sbjct: 122 CTNTSCSGHGECVETINNYTCKCDPGFSGLKCEQ 155
>pdb|1PFX|L Chain L, Porcine Factor Ixa
Length = 146
Score = 32.0 bits (71), Expect = 0.18, Method: Compositional matrix adjust.
Identities = 15/37 (40%), Positives = 19/37 (51%)
Query: 43 DHCLTDPCLGHGTCINRSDRYQCLCTPRYSGNNCEKD 79
D C +PCL G C + Y+C C + G NCE D
Sbjct: 49 DQCEPNPCLNGGLCKXDINSYECWCQVGFEGKNCELD 85
>pdb|1G1T|A Chain A, Crystal Structure Of E-Selectin LectinEGF DOMAINS
Complexed With Slex
Length = 157
Score = 32.0 bits (71), Expect = 0.18, Method: Compositional matrix adjust.
Identities = 14/34 (41%), Positives = 18/34 (52%)
Query: 45 CLTDPCLGHGTCINRSDRYQCLCTPRYSGNNCEK 78
C C GHG C+ + Y C C P +SG CE+
Sbjct: 122 CTNTSCSGHGECVETINNYTCKCDPGFSGLKCEQ 155
>pdb|1XKA|L Chain L, Factor Xa Complexed With A Synthetic Inhibitor
Fx-2212a,(2s)-(3'-
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid
pdb|1XKB|A Chain A, Factor Xa Complexed With A Synthetic Inhibitor
Fx-2212a,(2s)-(3'-
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid
pdb|1XKB|B Chain B, Factor Xa Complexed With A Synthetic Inhibitor
Fx-2212a,(2s)-(3'-
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid
pdb|1WU1|B Chain B, Factor Xa In Complex With The Inhibitor
4-[(5-Chloroindol-2-Yl)
Sulfonyl]-2-(2-Methylpropyl)-1-[[5-(Pyridin-4-Yl)
Pyrimidin-2- Yl]carbonyl]piperazine
Length = 95
Score = 31.6 bits (70), Expect = 0.23, Method: Compositional matrix adjust.
Identities = 19/49 (38%), Positives = 20/49 (40%), Gaps = 8/49 (16%)
Query: 43 DHCLTDPCLGHGTCINRSDRYQCLCTPRYSGNNCE--------KDNGDC 83
D C T PC G C Y C C + G NCE DNGDC
Sbjct: 4 DQCETSPCQNQGKCKXGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDC 52
>pdb|2I9A|A Chain A, Crystal Structure Of The Free Aminoterminal Fragment Of
Urokinase Type Plasminogen Activator (Atf)
pdb|2I9A|B Chain B, Crystal Structure Of The Free Aminoterminal Fragment Of
Urokinase Type Plasminogen Activator (Atf)
pdb|2I9A|C Chain C, Crystal Structure Of The Free Aminoterminal Fragment Of
Urokinase Type Plasminogen Activator (Atf)
pdb|2I9A|D Chain D, Crystal Structure Of The Free Aminoterminal Fragment Of
Urokinase Type Plasminogen Activator (Atf)
pdb|2I9B|A Chain A, Crystal Structure Of Atf-urokinase Receptor Complex
pdb|2I9B|B Chain B, Crystal Structure Of Atf-urokinase Receptor Complex
pdb|2I9B|C Chain C, Crystal Structure Of Atf-urokinase Receptor Complex
pdb|2I9B|D Chain D, Crystal Structure Of Atf-urokinase Receptor Complex
Length = 145
Score = 31.2 bits (69), Expect = 0.32, Method: Compositional matrix adjust.
Identities = 18/52 (34%), Positives = 26/52 (50%), Gaps = 3/52 (5%)
Query: 108 EIRDCTSN-PCLNDCVCVDDGNLS--FYCNCTEDFTGEYCQFENSAACVTLN 156
E+ SN CLN CV + S +CNC + F G++C+ + S C N
Sbjct: 5 ELHQVPSNCDCLNGGTCVSNKYFSNIHWCNCPKKFGGQHCEIDKSKTCYEGN 56
>pdb|3U73|A Chain A, Crystal Structure Of Stabilized Human Upar Mutant In
Complex With Atf
Length = 132
Score = 30.8 bits (68), Expect = 0.41, Method: Compositional matrix adjust.
Identities = 18/52 (34%), Positives = 26/52 (50%), Gaps = 3/52 (5%)
Query: 108 EIRDCTSN-PCLNDCVCVDDGNLS--FYCNCTEDFTGEYCQFENSAACVTLN 156
E+ SN CLN CV + S +CNC + F G++C+ + S C N
Sbjct: 3 ELHQVPSNCDCLNGGTCVSNKYFSNIHWCNCPKKFGGQHCEIDKSKTCYEGN 54
>pdb|3BT1|A Chain A, Structure Of Urokinase Receptor, Urokinase And Vitronectin
Complex
pdb|3BT2|A Chain A, Structure Of Urokinase Receptor, Urokinase And Vitronectin
Complex
Length = 135
Score = 30.8 bits (68), Expect = 0.42, Method: Compositional matrix adjust.
Identities = 18/52 (34%), Positives = 26/52 (50%), Gaps = 3/52 (5%)
Query: 108 EIRDCTSN-PCLNDCVCVDDGNLS--FYCNCTEDFTGEYCQFENSAACVTLN 156
E+ SN CLN CV + S +CNC + F G++C+ + S C N
Sbjct: 5 ELHQVPSNCDCLNGGTCVSNKYFSNIHWCNCPKKFGGQHCEIDKSKTCYEGN 56
>pdb|2YGQ|A Chain A, Wif Domain-Epidermal Growth Factor (Egf)-Like Domains 1-3
Of Human Wnt Inhibitory Factor 1 In Complex With
1,2-Dipalmitoylphosphatidylcholine
Length = 324
Score = 30.8 bits (68), Expect = 0.45, Method: Compositional matrix adjust.
Identities = 32/105 (30%), Positives = 44/105 (41%), Gaps = 21/105 (20%)
Query: 47 TDPCLGHGTCINRSDRYQCLCTPRYSGNNCEKDNGDCSSNPCLNDGVCVDEVYKGR---- 102
T C+ G C+ C+C P + G NC+K N CS+ C N G C Y G+
Sbjct: 184 TPRCMNGGLCVTPGF---CICPPGFYGVNCDKAN--CSTT-CFNGGTC---FYPGKCICP 234
Query: 103 ---YWELPEIRDCTSNPCLNDCVCVDDGNLSFYCNCTEDFTGEYC 144
E EI C PC N C+ C C++ + G+ C
Sbjct: 235 PGLEGEQCEISKC-PQPCRNGGKCIGKSK----CKCSKGYQGDLC 274
>pdb|1URK|A Chain A, Solution Structure Of The Amino Terminal Fragment Of
Urokinase-Type Plasminogen Activator
Length = 130
Score = 30.8 bits (68), Expect = 0.48, Method: Compositional matrix adjust.
Identities = 15/42 (35%), Positives = 22/42 (52%), Gaps = 2/42 (4%)
Query: 117 CLNDCVCVDDGNLS--FYCNCTEDFTGEYCQFENSAACVTLN 156
CLN CV + S +CNC + F G++C+ + S C N
Sbjct: 8 CLNGGTCVSNKYFSNIHWCNCPKKFGGQHCEIDKSKTCYEGN 49
>pdb|2E26|A Chain A, Crystal Structure Of Two Repeat Fragment Of Reelin
Length = 725
Score = 30.8 bits (68), Expect = 0.49, Method: Compositional matrix adjust.
Identities = 14/28 (50%), Positives = 19/28 (67%), Gaps = 3/28 (10%)
Query: 50 CLGHGTCINRSDRYQCLCTPRYSGNNCE 77
C GHG+CIN + +C+C P YSG C+
Sbjct: 192 CYGHGSCINGT---KCICDPGYSGPTCK 216
>pdb|3A7Q|A Chain A, Structural Basis For Specific Recognition Of Reelin By Its
Receptors
Length = 725
Score = 30.4 bits (67), Expect = 0.50, Method: Compositional matrix adjust.
Identities = 14/28 (50%), Positives = 19/28 (67%), Gaps = 3/28 (10%)
Query: 50 CLGHGTCINRSDRYQCLCTPRYSGNNCE 77
C GHG+CIN + +C+C P YSG C+
Sbjct: 192 CYGHGSCINGT---KCICDPGYSGPTCK 216
>pdb|2FD6|A Chain A, Structure Of Human Urokinase Plasminogen Activator In
Complex With Urokinase Receptor And An Anti-Upar
Antibody At 1.9 A
Length = 122
Score = 30.4 bits (67), Expect = 0.53, Method: Compositional matrix adjust.
Identities = 15/42 (35%), Positives = 22/42 (52%), Gaps = 2/42 (4%)
Query: 117 CLNDCVCVDDGNLS--FYCNCTEDFTGEYCQFENSAACVTLN 156
CLN CV + S +CNC + F G++C+ + S C N
Sbjct: 3 CLNGGTCVSNKYFSNIHWCNCPKKFGGQHCEIDKSKTCYEGN 44
>pdb|2W86|A Chain A, Crystal Structure Of Fibrillin-1 Domains
Cbegf9hyb2cbegf10, Calcium Saturated Form
Length = 147
Score = 30.4 bits (67), Expect = 0.61, Method: Compositional matrix adjust.
Identities = 16/28 (57%), Positives = 19/28 (67%), Gaps = 1/28 (3%)
Query: 10 TLCESDINECETVKDVCNYGICVNTNGN 37
T CE DI+ECE VC G+CVNT G+
Sbjct: 102 TQCE-DIDECEVFPGVCKNGLCVNTRGS 128
>pdb|1APO|A Chain A, Three-Dimensional Structure Of The Apo Form Of The N-
Terminal Egf-Like Module Of Blood Coagulation Factor X
As Determined By Nmr Spectroscopy And Simulated Folding
Length = 42
Score = 30.0 bits (66), Expect = 0.68, Method: Compositional matrix adjust.
Identities = 14/35 (40%), Positives = 16/35 (45%)
Query: 43 DHCLTDPCLGHGTCINRSDRYQCLCTPRYSGNNCE 77
D C PCL G C + Y C C + G NCE
Sbjct: 4 DQCEGHPCLNQGHCKDGIGDYTCTCAEGFEGKNCE 38
Score = 28.5 bits (62), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 15/35 (42%), Positives = 19/35 (54%), Gaps = 1/35 (2%)
Query: 112 CTSNPCLNDCVCVDDGNLSFYCNCTEDFTGEYCQF 146
C +PCLN C DG + C C E F G+ C+F
Sbjct: 6 CEGHPCLNQGHC-KDGIGDYTCTCAEGFEGKNCEF 39
>pdb|1WHE|A Chain A, Coagulation Factor, Nmr, 20 Structures
pdb|1WHF|A Chain A, Coagulation Factor, Nmr, 15 Structures
Length = 86
Score = 29.6 bits (65), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 14/35 (40%), Positives = 15/35 (42%)
Query: 43 DHCLTDPCLGHGTCINRSDRYQCLCTPRYSGNNCE 77
D C PCL G C Y C C + G NCE
Sbjct: 48 DQCEGHPCLNQGHCKXGIGDYTCTCAEGFEGKNCE 82
Score = 26.6 bits (57), Expect = 8.0, Method: Compositional matrix adjust.
Identities = 18/55 (32%), Positives = 24/55 (43%), Gaps = 2/55 (3%)
Query: 93 VCVDEVYKGRYWELPEIRD-CTSNPCLNDCVCVDDGNLSFYCNCTEDFTGEYCQF 146
V D +W + D C +PCLN C G + C C E F G+ C+F
Sbjct: 30 VFXDAXQTDXFWSKYKDGDQCEGHPCLNQGHC-KXGIGDYTCTCAEGFEGKNCEF 83
>pdb|1CCF|A Chain A, How An Epidermal Growth Factor (Egf)-Like Domain Binds
Calcium-High Resolution Nmr Structure Of The Calcium
Form Of The Nh2-Terminal Egf-Like Domain In Coagulation
Factor X
Length = 42
Score = 29.3 bits (64), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 14/35 (40%), Positives = 15/35 (42%)
Query: 43 DHCLTDPCLGHGTCINRSDRYQCLCTPRYSGNNCE 77
D C PCL G C Y C C + G NCE
Sbjct: 4 DQCEGHPCLNQGHCKXGIGDYTCTCAEGFEGKNCE 38
Score = 26.6 bits (57), Expect = 9.2, Method: Compositional matrix adjust.
Identities = 14/35 (40%), Positives = 18/35 (51%), Gaps = 1/35 (2%)
Query: 112 CTSNPCLNDCVCVDDGNLSFYCNCTEDFTGEYCQF 146
C +PCLN C G + C C E F G+ C+F
Sbjct: 6 CEGHPCLNQGHC-KXGIGDYTCTCAEGFEGKNCEF 39
>pdb|1EMN|A Chain A, Nmr Study Of A Pair Of Fibrillin Ca2+ Binding Epidermal
Growth Factor-Like Domains, Minimized Average Structure
pdb|1EMO|A Chain A, Nmr Study Of A Pair Of Fibrillin Ca2+ Binding Epidermal
Growth Factor-Like Domains, 22 Structures
Length = 82
Score = 28.9 bits (63), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 24/73 (32%), Positives = 37/73 (50%), Gaps = 17/73 (23%)
Query: 15 DINECETVKDVCNYGICVNTNGN------------GNSKVDH---CLTDPCLGHGTCINR 59
D++EC+ DVC +G C+NT+G+ GN VD + +PC G+GTC N
Sbjct: 4 DMDECKE-PDVCKHGQCINTDGSYRCECPFGYILAGNECVDTDECSVGNPC-GNGTCKNV 61
Query: 60 SDRYQCLCTPRYS 72
++C C +
Sbjct: 62 IGGFECTCEEGFE 74
Score = 27.3 bits (59), Expect = 5.2, Method: Compositional matrix adjust.
Identities = 21/52 (40%), Positives = 25/52 (48%), Gaps = 4/52 (7%)
Query: 42 VDHCLTDPCLGHGTCINRSDRYQCLCTPRY--SGNNCEKDNGDCS-SNPCLN 90
+D C HG CIN Y+C C Y +GN C D +CS NPC N
Sbjct: 5 MDECKEPDVCKHGQCINTDGSYRCECPFGYILAGNEC-VDTDECSVGNPCGN 55
>pdb|1UZJ|A Chain A, Integrin Binding Cbegf22-Tb4-Cbegf33 Fragment Of Human
Fibrillin-1, Holo Form.
pdb|1UZJ|B Chain B, Integrin Binding Cbegf22-Tb4-Cbegf33 Fragment Of Human
Fibrillin-1, Holo Form.
pdb|1UZJ|C Chain C, Integrin Binding Cbegf22-Tb4-Cbegf33 Fragment Of Human
Fibrillin-1, Holo Form.
pdb|1UZP|A Chain A, Integrin Binding Cbegf22-Tb4-Cbegf33 Fragment Of Human
Fibrillin-1, Sm Bound Form Cbegf23 Domain Only.
pdb|1UZQ|A Chain A, Integrin Binding Cbegf22-Tb4-Cbegf33 Fragment Of Human
Fibrillin-1, Apo Form Cbegf23 Domain Only
Length = 162
Score = 28.9 bits (63), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 13/35 (37%), Positives = 23/35 (65%), Gaps = 1/35 (2%)
Query: 3 FKPISLSTLCESDINECETVKDVCNYGICVNTNGN 37
F+P ++ + E DI+EC+ + +C G C+NT G+
Sbjct: 110 FRPNPITVILE-DIDECQELPGLCQGGKCINTFGS 143
>pdb|1UZK|A Chain A, Integrin Binding Cbegf22-tb4-cbegf33 Fragment Of Human
Fibrillin-1, Ca Bound To Cbegf23 Domain Only
Length = 162
Score = 28.9 bits (63), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 13/35 (37%), Positives = 23/35 (65%), Gaps = 1/35 (2%)
Query: 3 FKPISLSTLCESDINECETVKDVCNYGICVNTNGN 37
F+P ++ + E DI+EC+ + +C G C+NT G+
Sbjct: 110 FRPNPITVILE-DIDECQELPGLCQGGKCINTFGS 143
>pdb|3F6U|L Chain L, Crystal Structure Of Human Activated Protein C (Apc)
Complexed With Ppack
Length = 98
Score = 28.5 bits (62), Expect = 2.4, Method: Compositional matrix adjust.
Identities = 16/52 (30%), Positives = 24/52 (46%), Gaps = 9/52 (17%)
Query: 42 VDHCLTDPCLGHGTCINRSDRYQCLCTPRYSGNNCEK---------DNGDCS 84
++H C GHGTCI+ + C C + G C++ DNG C+
Sbjct: 7 LEHPCASLCCGHGTCIDGIGSFSCDCRSGWEGRFCQREVSFLNCSLDNGGCT 58
>pdb|2GY5|A Chain A, Tie2 Ligand-Binding Domain Crystal Structure
pdb|2GY7|B Chain B, Angiopoietin-2TIE2 COMPLEX CRYSTAL STRUCTURE
Length = 423
Score = 27.7 bits (60), Expect = 3.9, Method: Compositional matrix adjust.
Identities = 19/56 (33%), Positives = 27/56 (48%), Gaps = 10/56 (17%)
Query: 61 DRYQ-CLCTPRYSGNNCEKDNGDCSSNPCLNDGVCVDEVYKGRY--------WELP 107
DR+Q CLC+P + G CE++ G P + D EV G++ W LP
Sbjct: 302 DRFQGCLCSPGWQGLQCERE-GIPRMTPKIVDLPDHIEVNSGKFNPICKASGWPLP 356
>pdb|1AUT|L Chain L, Human Activated Protein C
Length = 114
Score = 27.3 bits (59), Expect = 5.0, Method: Compositional matrix adjust.
Identities = 16/52 (30%), Positives = 23/52 (44%), Gaps = 9/52 (17%)
Query: 42 VDHCLTDPCLGHGTCINRSDRYQCLCTPRYSGNNCEK---------DNGDCS 84
++H C GHGTCI + C C + G C++ DNG C+
Sbjct: 14 LEHPCASLCCGHGTCIXGIGSFSCDCRSGWEGRFCQREVSFLNCSLDNGGCT 65
>pdb|4GI3|C Chain C, Crystal Structure Of Greglin In Complex With Subtilisin
Length = 83
Score = 27.3 bits (59), Expect = 5.4, Method: Compositional matrix adjust.
Identities = 24/84 (28%), Positives = 32/84 (38%), Gaps = 13/84 (15%)
Query: 90 NDGVCVDEVYKGRYWELPEIRDCTSNPCLNDCVCVDDGNLSFY----------CNCTEDF 139
+DG E + Y ELP C P + VCV+D N FY C C F
Sbjct: 3 DDGSASPESQEMSYTELPCPSIC---PLIYAPVCVEDSNQDFYLFVNECEVRKCGCEAGF 59
Query: 140 TGEYCQFENSAACVTLNPCQNNAT 163
+ E A +L P Q ++
Sbjct: 60 VYTFVPREMCKATTSLCPMQTKSS 83
>pdb|3R05|A Chain A, Structure Of Neurexin 1 Alpha (Domains Lns1-Lns6), With
Splice Insert Ss3
pdb|3R05|B Chain B, Structure Of Neurexin 1 Alpha (Domains Lns1-Lns6), With
Splice Insert Ss3
Length = 1254
Score = 26.9 bits (58), Expect = 5.6, Method: Compositional matrix adjust.
Identities = 14/36 (38%), Positives = 23/36 (63%), Gaps = 1/36 (2%)
Query: 45 CLTDPCLGHGTCINRSDRYQCLCTPR-YSGNNCEKD 79
CL++PC +G C + +RY C C+ Y G +CE++
Sbjct: 622 CLSNPCKNNGMCRDGWNRYVCDCSGTGYLGRSCERE 657
>pdb|3QCW|A Chain A, Structure Of Neurexin 1 Alpha (Domains Lns1-Lns6), No
Splice Inserts
pdb|3QCW|B Chain B, Structure Of Neurexin 1 Alpha (Domains Lns1-Lns6), No
Splice Inserts
Length = 1245
Score = 26.9 bits (58), Expect = 6.0, Method: Compositional matrix adjust.
Identities = 14/36 (38%), Positives = 23/36 (63%), Gaps = 1/36 (2%)
Query: 45 CLTDPCLGHGTCINRSDRYQCLCTPR-YSGNNCEKD 79
CL++PC +G C + +RY C C+ Y G +CE++
Sbjct: 622 CLSNPCKNNGMCRDGWNRYVCDCSGTGYLGRSCERE 657
>pdb|3POY|A Chain A, Crystal Structure Of The Alpha-Neurexin-1 Ectodomain, Lns
2-6
Length = 1019
Score = 26.9 bits (58), Expect = 6.0, Method: Compositional matrix adjust.
Identities = 14/36 (38%), Positives = 23/36 (63%), Gaps = 1/36 (2%)
Query: 45 CLTDPCLGHGTCINRSDRYQCLCTPR-YSGNNCEKD 79
CL++PC +G C + +RY C C+ Y G +CE++
Sbjct: 397 CLSNPCKNNGMCRDGWNRYVCDCSGTGYLGRSCERE 432
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.320 0.137 0.475
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 6,376,206
Number of Sequences: 62578
Number of extensions: 292695
Number of successful extensions: 873
Number of sequences better than 100.0: 144
Number of HSP's better than 100.0 without gapping: 71
Number of HSP's successfully gapped in prelim test: 73
Number of HSP's that attempted gapping in prelim test: 578
Number of HSP's gapped (non-prelim): 319
length of query: 181
length of database: 14,973,337
effective HSP length: 93
effective length of query: 88
effective length of database: 9,153,583
effective search space: 805515304
effective search space used: 805515304
T: 11
A: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.8 bits)
S2: 48 (23.1 bits)